Skip to main content
Caplight Logo









Genexa

Genexa

Private
Atlanta, GeorgiaHealthcare & Life Scienceshttps://www.genexa.com/

Last Round

Series A

Jul 14, 2021

Est. Valuation

$200M

Total Funding Raised

$60.5M

Company Overview

Genexa is a pharmaceutical company that develops and markets clean over-the-counter medicines using effective active ingredients without artificial inactive ingredients.

Sector

Healthcare & Life Sciences

Verticals

D2C Brands, E-commerce, Home & Lifestyle

Business Model

B2C

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

clean medicineover-the-counter medicineOTCclean labelnatural medicinepediatric healthconsumer packaged goodsCPGingredient transparencynon-GMOchildren's pain reliefB CorpD2Cwellness brands

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Genexa Comparables

Compare Genexa with similar companies based on industry and business-model similarity.

Genexa comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
KinderFarms
82%
EEZ Co.
81%
Hyland's Naturals
79%

Genexa Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJul 14, 2021
Growth EquityNov 20, 2018
Convertible DebtNov 20, 2018

Key People

Founding team and executive leadership

Ana Silva

Chief Financial Officer

Executive Team

Genexa Investors

Notable investors and investment history

Genexa investors
InvestorRounds
Platinum Mile VenturesSeries A
VerlinvestSeries A
North Castle PartnersSeries A
Monogram Capital PartnersSeries A
Point King CapitalSeries A
Unilever VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 14, 2021

    $60M round led by Monogram Capital Partners.

Genexa Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Genexa Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Genexa's valuation, stock price, and market status.

Firmographic Details

HeadquartersAtlanta, Georgia
Employee Range26
Year Founded2014
Last FundingJul 14, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?